Meihua International Medical Technologies Co. Ltd. Ordinary Shares(Mhua) Financials: Return On Equity Compared To Industry Average, Plus Other Key Ratios

Profitability Trend (Last 5 Years)

Profitability - return on equity

This chart shows the historical trend of return on equity for MHUA compared to its industry average over the recent years.

Ratio Definition and Interpretation

Name: Return on Equity (ROE)

Definition: ROE shows how much profit the company earns for its shareholders based on their invested equity. It’s one of the most watched profitability ratios. A consistently high ROE signals strong management and efficient use of shareholder capital. But artificially high ROE may sometimes be boosted by excessive debt.

Interpretation:
• In '2021', MHUA's return on equity was 19.4%, measuring profitability for shareholders. Industry average for Medical/Dental Instruments in '2021' stood at -17.3%.
• In '2022', MHUA's return on equity was 5.1%, measuring profitability for shareholders. The decline from '2021' may indicate some operational or financial challenges. Industry average for Medical/Dental Instruments in '2022' stood at -44.7%. Industry average declined by 27.4% from previous year.
• In '2023', MHUA's return on equity was 8.2%, measuring profitability for shareholders. The increase since '2022' reflects strengthening financial performance. Industry average for Medical/Dental Instruments in '2023' stood at -74.1%. Industry average declined by 29.3% from previous year.
• In '2024', MHUA's return on equity was 7.1%, measuring profitability for shareholders. The decline from '2023' may indicate some operational or financial challenges. Industry average for Medical/Dental Instruments in '2024' stood at -45.9%. Industry average increased by 28.1% compared to previous year.
Overall, MHUA's return on equity has been volatile but showed a downward trend over the past 4 years.

Formula: ROE = Net Income / Shareholders' Equity

Good Range: 10%-20% desirable for many industries.